| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.22 | 0.0005 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.22 | 0.0008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.19 | 0.004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.19 | 0.004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.15 | 0.03 |